01 1Cipla Limited.
01 1Pharmapia Co., Ltd.
01 1Ambrisentan
01 1India
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-02-18
Registration Number : Su258-30-ND
Manufacturer Name : Cipla Limited.
Manufacturer Address : Plot Nos. A-2, A-33 & A-37/2/2,MIDC, Patalganga, Raigad 410220 Maharashtra State, Ind...
95
PharmaCompass offers a list of Ambrisentan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Ambrisentan manufacturer or Ambrisentan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ambrisentan manufacturer or Ambrisentan supplier.
A Ambrisentan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ambrisentan, including repackagers and relabelers. The FDA regulates Ambrisentan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ambrisentan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ambrisentan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Ambrisentan supplier is an individual or a company that provides Ambrisentan active pharmaceutical ingredient (API) or Ambrisentan finished formulations upon request. The Ambrisentan suppliers may include Ambrisentan API manufacturers, exporters, distributors and traders.
click here to find a list of Ambrisentan suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ambrisentan Drug Master File in Korea (Ambrisentan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ambrisentan. The MFDS reviews the Ambrisentan KDMF as part of the drug registration process and uses the information provided in the Ambrisentan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ambrisentan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ambrisentan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ambrisentan suppliers with KDMF on PharmaCompass.
